Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on May 20, 2025
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer
GlobeNewswire
·
May 20, 2025
These results indicate that EXACT Therapeutics’ Acoustic Cluster Therapy (ACT®) significantly enhances the local effect of chemotherapy In the patients who had a response to chemotherapy, ACT-treated tumours showed a significantly greater reduction in …
Goldman Sachs Boosts Holdings in BlackRock’s Bitcoin ETF; PAIRMiner Highlights Growth in Cloud Mining Participation
GlobeNewswire
·
May 20, 2025
PAIRMiner Image LOS ANGELES, May 20, 2025 (GLOBE NEWSWIRE) -- Institutional confidence in Bitcoin continues to rise, as Goldman Sachs recently increased its holdings in BlackRock’s iShares Bitcoin Trust (IBIT) by 28%. Now holding over 30.8 million shares …
One Trading Approved Under MiCAR - First EU Venue for Regulated Crypto Spot and Derivatives
GlobeNewswire
·
May 20, 2025
Amsterdam, Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- One Trading Exchange B.V. (One Trading), a leading European trading platform, has officially become the first crypto derivatives trading venue in the European Union to be authorised under both MiFID …
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
GlobeNewswire
·
May 20, 2025
Allschwil, Switzerland, May 20, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that its antibiotic …
Basilea gibt Verkaufsstart seines Antibiotikums Zevtera® (Ceftobiprol) in den USA bekannt
GlobeNewswire
·
May 20, 2025
Allschwil, 20. Mai 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
GlobeNewswire
·
May 20, 2025
VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today the appointment of Rick Austin, Ph.D. as Chief Scientific …
Reverse Phone Lookup: Why Spokeo Is the Best Option
GlobeNewswire
·
May 20, 2025
New York, May 19, 2025 (GLOBE NEWSWIRE) -- In an era where spam calls, fraud, and anonymous numbers are increasingly common, the need for a reliable reverse phone lookup tool has never been greater, and Spokeo has established itself as the leading choice …
CRYPTO MINING FIRM launches a revolutionary free cloud mining platform to provide global Bitcoin (BTC), Dogecoin (DOGE) and Ripple (XRP) users with income and profits
GlobeNewswire
·
May 20, 2025
Miami, Florida, USA, May 19, 2025 (GLOBE NEWSWIRE) -- After taking office, US President Trump set five cryptocurrencies, including Bitcoin (BTC), Ripple (XRP), and Solana (SOL), as strategic reserves, which means that the era of encryption has arrived. At …
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
GlobeNewswire
·
May 20, 2025
BERKELEY, Calif. and MAINZ, Germany, May 19, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the pricing of a …